Teladoc Health Announces Employee Inducement Awards Under NYSE Rule 303A.08
Teladoc Health (NYSE:TDOC) has granted inducement awards to two new non-executive employees, effective November 1, 2024. The awards consist of restricted stock units covering 70,575 shares of common stock. The vesting schedule includes one-third of shares on the first anniversary, with the remaining shares vesting quarterly over the following two years. These awards were approved by the Compensation Committee under the 2023 Employment Inducement Incentive Award Plan, complying with NYSE Rule 303A.08.
Teladoc Health (NYSE:TDOC) ha concesso premi di incentivazione a due nuovi dipendenti non esecutivi, a partire dal 1° novembre 2024. I premi consistono in unità di azioni limitate che coprono 70.575 azioni di azionariato comune. Il programma di maturazione prevede che un terzo delle azioni maturi al primo anniversario, mentre le rimanenti azioni matureranno trimestralmente nei due anni successivi. Questi premi sono stati approvati dal Comitato di Compensazione ai sensi del Piano di Incentivazione all'Impiego 2023, in conformità con la Regola 303A.08 della NYSE.
Teladoc Health (NYSE:TDOC) ha otorgado premios de incentivo a dos nuevos empleados no ejecutivos, con fecha efectiva del 1 de noviembre de 2024. Los premios consisten en unidades de acciones restringidas que abarcan 70,575 acciones comunes. El cronograma de adquisición incluye un tercio de las acciones en el primer aniversario, y las acciones restantes se adquirirán trimestralmente durante los dos años siguientes. Estos premios fueron aprobados por el Comité de Compensación bajo el Plan de Incentivo de Empleo 2023, cumpliendo con la Regla 303A.08 de la NYSE.
Teladoc Health (NYSE:TDOC)는 2024년 11월 1일부터 적용되는 두 명의 신규 비임원 직원에게 유인상금을 부여했습니다. 이 상금은 70,575 주의 보통주를 포함하는 제한된 주식 단위로 구성됩니다. 주식의 획득 일정은 첫 번째 기념일에 1/3의 주식을 포함하고, 나머지 주식은 이후 2년 동안 분기마다 획득됩니다. 이 상금은 2023년 고용 유인 상금 계획에 따라 보상 위원회에 의해 승인되었으며, NYSE 규칙 303A.08을 준수합니다.
Teladoc Health (NYSE:TDOC) a accordé des primes d'incitation à deux nouveaux employés non exécutifs, à compter du 1er novembre 2024. Les primes sont constituées d'unités d'actions restreintes couvrant 70 575 actions ordinaires. Le calendrier d'acquisition prévoit qu'un tiers des actions soit acquis au premier anniversaire, tandis que les actions restantes seront acquises trimestriellement au cours des deux années suivantes. Ces primes ont été approuvées par le Comité de Rémunération dans le cadre du Plan d'Incentive à l'Emploi 2023, conformément à la Règle 303A.08 de la NYSE.
Teladoc Health (NYSE:TDOC) hat zwei neuen nicht-executiven Mitarbeitern ab dem 1. November 2024 Anreizvergütungen gewährt. Die Vergütungen bestehen aus eingeschränkten Aktieneinheiten, die 70.575 Stammaktien abdecken. Der Vesting-Zeitplan sieht vor, dass ein Drittel der Aktien am ersten Jahrestag, und die verbleibenden Aktien vierteljährlich über die folgenden zwei Jahre erworben werden. Diese Vergütungen wurden vom Vergütungsausschuss im Rahmen des 2023 Employment Inducement Incentive Award Plans genehmigt und entsprechen der NYSE-Regel 303A.08.
- Strategic talent acquisition with equity-based compensation to align employee interests with shareholders
- Potential shareholder dilution from issuance of 70,575 new shares
PURCHASE, NY, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that it issued inducement awards to two new employees.
Effective November 1, 2024, in connection with commencing employment, two new non-executive employees of Teladoc Health were granted awards of restricted stock units covering an aggregate of 70,575 shares of Teladoc Health’s common stock, par value
About Teladoc Health
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Teladoc Health leverages more than two decades of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit www.teladochealth.com
Media:
Chris Stenrud
860-491-8821
pr@teladochealth.com
FAQ
How many shares were granted in Teladoc Health's (TDOC) November 2024 inducement awards?
What is the vesting schedule for Teladoc Health's (TDOC) November 2024 inducement awards?
When did Teladoc Health (TDOC) issue the November 2024 inducement awards?
